drugset / Trial / NCT07220447

L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance

NCT07220447

RandomizedParallel-groupOpen-labelSupportive care

Summary

This clinical trial tests the feasibility, best dose, and effectiveness of L-theanine for supporting relaxation and mood among cancer patients in surveillance. L-theanine is a substance found in the leaves of green tea with potential to enhance mental health and well-being. It works by increasing certain chemicals within the body that have been associated with stress reduction, mood stabilization, and improved cognitive performance.

Timeline

Start
2026-04-21
Primary completion
2027-07-09
Completion
2027-07-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Theanine Small molecule 200 mg Oral